Understanding how treatment effects vary across groups is central to policy evaluation. In Difference-in-Differences designs, heterogeneity is often studied using subgroup or triple-difference analyses, which can suffer from conservative inference, reliance on parametric interaction structures, and sensitivity to differences in covariate distributions across groups. We propose the Balanced Group Average Treatment Effect on the Treated (BGATT), a new estimand that isolates heterogeneity in treatment responses from differences in covariate composition and is identified under standard conditional parallel-trends assumptions. BGATT provides a transparent target for comparing group-specific treatment effects. We derive an influence-function representation and develop estimators that are square-root-consistent and asymptotically normal under flexible machine-learning estimation of high-dimensional nuisance components, enabling valid inference on both group-specific effects and differences across groups. Simulation evidence shows favorable finite-sample performance, and an application to NLSY97 data illustrates how BGATT clarifies whether observed differences across gender reflect true heterogeneity or compositional differences.
Presented by:
Nadja van 't Hoff (University of Amsterdam)
Date & time:
June 10, 2026 12:30 pm - June 10, 2026 1:30 pm
Venue:
Online
External seminars home